Literature DB >> 16047340

IL-15 induces mast cell migration via a pertussis toxin-sensitive receptor.

Nicole E Jackson1, Hong-Wei Wang, Nicodemus Tedla, H Patrick McNeil, Carolyn L Geczy, Andrew Collins, Michael C Grimm, Taline Hampartzoumian, John E Hunt.   

Abstract

IL-15 induces proliferation, inhibits apoptosis and increases IL-4 production in murine mast cells. There is evidence that these activities are mediated via the uncharacterised receptor, IL-15R-X, rather than the classical three-chain IL-15 receptor. Effects of IL-15 on important aspects of mast cell biology, such as migration and degranulation, are unknown. We report that IL-15 induces migration of murine and human mast cells in a dose-dependent and biphasic manner, with peaks of migration occurring at approximately 10(-15) and approximately 10(-9) M. The potency of the response was similar to that induced by other well-established mast cell chemoattractants. Competition assays performed with murine and human mast cells indicate that both peaks of migration are due to chemotaxis. Pre-treatment of cells with pertussis toxin (PTX), a guanine nucleotide-binding regulatory protein (G-protein) inhibitor, resulted in complete inhibition of murine mast cell migration at approximately 10(-15) M IL-15, and human mast cell migration at approximately 10(-15) and approximately 10(-9) M. This demonstrates that murine and human mast cells express a PTX-sensitive receptor, activated in response to IL-15. Additionally, IL-15 did not induce degranulation in murine mast cells. Locally-produced IL-15 may contribute to mast cell recruitment during inflammatory responses, thereby acting as a linking cytokine between innate and adaptive arms of the immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047340     DOI: 10.1002/eji.200526154

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

2.  Actin reorganization is involved in vasoactive intestinal peptide induced human mast cells priming to fraktalkine-induced chemotaxis.

Authors:  Amr E El-Shazly
Journal:  Int J Gen Med       Date:  2008-11-30

Review 3.  Mast cells, glia and neuroinflammation: partners in crime?

Authors:  Stephen D Skaper; Laura Facci; Pietro Giusti
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

4.  Novel identified receptors on mast cells.

Authors:  Helena Migalovich-Sheikhet; Sheli Friedman; David Mankuta; Francesca Levi-Schaffer
Journal:  Front Immunol       Date:  2012-08-02       Impact factor: 7.561

5.  Investigation of the lower resistance meridian: speculation on the pathophysiological functions of acupuncture meridians.

Authors:  Weisheng Yang
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-02       Impact factor: 2.629

6.  Genomic analysis of the appearance of ovarian mast cells in neonatal MRL/MpJ mice.

Authors:  Teppei Nakamura; Yuko Sakata; Saori Otsuka-Kanazawa; Osamu Ichii; Masataka Chihara; Ken-ichi Nagasaki; Yuka Namiki; Yasuhiro Kon
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 7.  An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.

Authors:  Stephen D Skaper; Laura Facci; Morena Zusso; Pietro Giusti
Journal:  Front Cell Neurosci       Date:  2018-03-21       Impact factor: 5.505

Review 8.  Human and Murine Evidence for Mechanisms Driving Autoimmune Photosensitivity.

Authors:  Sonya J Wolf; Shannon N Estadt; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

9.  Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor.

Authors:  Afsaneh Soruri; Jasmin Grigat; Ziba Kiafard; Jörg Zwirner
Journal:  BMC Immunol       Date:  2008-06-17       Impact factor: 3.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.